Amicus opens gene therapy ‘research engine’ in Philadelphia 11-Mar-2020 By Ben Hargreaves Amicus announces the opening of a gene therapy center that has been established in partnership with the University of Pennsylvania.
July roundup sees flurry of partnership deals 29-Jul-2019 By Ben Hargreaves The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.
Amicus picks Brammer for preclinical, clinical gene therapy work 02-Jul-2019 By Vassia Barba Rare disease drug developer to work with Brammer Bio – which Thermo Fisher acquired in March – on gene therapy programs against Batten disease.
WuXi Biologics enters first commercial manufacturing agreement 13-Feb-2019 By Ben Hargreaves WuXi Biologics agrees five-year deal with Amicus for the commercial production of a biologic for the treatment of Pompe disease.